4-Hydroxy-17(Z)-picolinylidene-4,6-androstadien-3-one showed markedly strong cytotoxicity (IC50 9.3 μM) against the MDA-MB231 cancer cell line, while also exhibiting a pronounced aromatase inhibition (92%). This evidence concerns the gene CYP19A1 and cancer.